Skip to main content

Table 7 Proviral load for each HLA-B allele and clinical status

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

Allele

Population

Mean PVL

AC

ATLL

HAM

HLA-B*07

11.83*

11.83

HLA-B*08

0.39*

15.12

10.21

HLA-B*13

35.1*

35.1

HLA-B*14

5.3*

1.3*

3.58**

3.44

HLA-B*15

3.07**

3.07

HLA-B*18

0.82**

0.81

HLA-B*35

5.1**

6.44

6.12

HLA-B*38

2.1**

2.1

HLA-B*39

0.24

18.78

7.84

10.36

HLA-B*41

ND

ND

HLA-B*44

0.58*

33.98*

29.54*

21.36

HLA-B*48

1.24

1.24

HLA-B*49

35.1*

35.1

HLA-B*51

0.74

12.49*

3.7

4.11

HLA-B*52

0.57*

9.32**

6.41

HLA-B*53

3.42

3.42

HLA-B*55

4.03*

4.03

  1. AC asymptomatics carriers, HAM HTLV-1 associated myelopathy, ATLL Adult T cell leukemia/lymphoma, NII Non-infected Individuals, HLA Human leukocyte antigen, PVL proviral load
  2. *Only the PVL of one allele was available, **Mean PVL of two alleles